Journal of Neurochemistry, ISSN 0022-3042, 02/2016, Volume 136, Issue 4, pp. 731 - 740
Prion diseases are a group of neurodegenerative diseases characterized by neuronal loss and spongiform degeneration, astrogliosis and aggregation of scrapie...
DKK‐1 | Wnt/β‐catenin signaling | Prion diseases | GSK‐3β | β‐catenin | scrapie | Wnt/β-catenin signaling | GSK-3β | β-catenin | DKK-1
DKK‐1 | Wnt/β‐catenin signaling | Prion diseases | GSK‐3β | β‐catenin | scrapie | Wnt/β-catenin signaling | GSK-3β | β-catenin | DKK-1
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2012, Volume 27, Issue 11, pp. 2242 - 2250
Glucocorticoids (GCs) are potent anti‐inflammatory drugs, but their use is limited by their adverse effects on the skeleton. Compound A (CpdA) is a novel GC...
DKK‐1 | COMPOUND A | GLUCOCORTICOID‐INDUCED OSTEOPOROSIS | RANKL | BONE REMODELING | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | DKK-1 | INDUCED OSTEOPOROSIS | CELLS | OSTEOPROTEGERIN | MECHANISMS | PLANT-ORIGIN | INHIBITION | OSTEOBLASTS | ENDOCRINOLOGY & METABOLISM | LIGAND | DIFFERENTIATION | Anti-Inflammatory Agents - pharmacology | Humans | Osteoblasts - drug effects | Osteogenesis - drug effects | Receptors, Glucocorticoid - metabolism | Receptors, Glucocorticoid - agonists | Bone Density - drug effects | Animals | Cell Differentiation - drug effects | Models, Biological | Glucocorticoids - pharmacology | Mice | Osteoblasts - cytology | Osteoblasts - metabolism | Osteoporosis | Corticosteroids | Peptides | Analysis | Genes | Bones | Universities and colleges | Gene expression | Density | Prednisolone | Steroids | Antiinflammatory agents | Glucocorticoids | Spine | Osteocytes | procollagen | Bone turnover | Osteoblasts | Osteoprotegerin | Apposition | Bone histomorphometry | NF- Kappa B protein | Bone marrow | Bone mineral density | Skeleton | Bone loss | Dkk1 protein | TRANCE protein | Osteogenesis
DKK‐1 | COMPOUND A | GLUCOCORTICOID‐INDUCED OSTEOPOROSIS | RANKL | BONE REMODELING | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | DKK-1 | INDUCED OSTEOPOROSIS | CELLS | OSTEOPROTEGERIN | MECHANISMS | PLANT-ORIGIN | INHIBITION | OSTEOBLASTS | ENDOCRINOLOGY & METABOLISM | LIGAND | DIFFERENTIATION | Anti-Inflammatory Agents - pharmacology | Humans | Osteoblasts - drug effects | Osteogenesis - drug effects | Receptors, Glucocorticoid - metabolism | Receptors, Glucocorticoid - agonists | Bone Density - drug effects | Animals | Cell Differentiation - drug effects | Models, Biological | Glucocorticoids - pharmacology | Mice | Osteoblasts - cytology | Osteoblasts - metabolism | Osteoporosis | Corticosteroids | Peptides | Analysis | Genes | Bones | Universities and colleges | Gene expression | Density | Prednisolone | Steroids | Antiinflammatory agents | Glucocorticoids | Spine | Osteocytes | procollagen | Bone turnover | Osteoblasts | Osteoprotegerin | Apposition | Bone histomorphometry | NF- Kappa B protein | Bone marrow | Bone mineral density | Skeleton | Bone loss | Dkk1 protein | TRANCE protein | Osteogenesis
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2014, Volume 14, Issue 1, p. 649
Background: The Wnt inhibitor Dickkopf-1 (DKK-1) has been linked to the progression of malignant bone disease by impairing osteoblast activity. In addition,...
DKK-1 | Prostate cancer | Prognosis | MULTIPLE-MYELOMA | DKK 1 | ONCOLOGY | BONE | EXPRESSION | Multivariate Analysis | Prostatic Neoplasms - pathology | Tissue Array Analysis | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Intercellular Signaling Peptides and Proteins - blood | Biomarkers, Tumor - blood | Survival Analysis | Prostatic Neoplasms - blood | Aged | Complications and side effects | Care and treatment | Cancer patients | Multiple myeloma | Development and progression | Research | Health aspects | Risk factors
DKK-1 | Prostate cancer | Prognosis | MULTIPLE-MYELOMA | DKK 1 | ONCOLOGY | BONE | EXPRESSION | Multivariate Analysis | Prostatic Neoplasms - pathology | Tissue Array Analysis | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Intercellular Signaling Peptides and Proteins - blood | Biomarkers, Tumor - blood | Survival Analysis | Prostatic Neoplasms - blood | Aged | Complications and side effects | Care and treatment | Cancer patients | Multiple myeloma | Development and progression | Research | Health aspects | Risk factors
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2006, Volume 119, Issue 7, pp. 1728 - 1731
Dickkopf‐1 (DKK‐1) protein, a soluble inhibitor of Wnt signalling, has been implicated in the pathogenesis of myeloma bone disease through the suppression of...
multiple myeloma | osteoblasts | dickkopf‐1 (DKK‐1) | bone disease | autologous stem cell transplantation | Bone disease | Osteoblasts | Autologous stem cell transplantation | Dickkopf-1 (DKK-1) | Multiple myeloma | ONCOLOGY | UNDETERMINED SIGNIFICANCE | MONOCLONAL GAMMOPATHY | INHIBITOR | BONE-RESORPTION | Multiple Myeloma - diagnosis | Humans | Middle Aged | Male | Transplantation, Autologous | Intercellular Signaling Peptides and Proteins - blood | Biomarkers, Tumor - blood | Stem Cell Transplantation | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Multiple Myeloma - surgery | Multiple Myeloma - blood
multiple myeloma | osteoblasts | dickkopf‐1 (DKK‐1) | bone disease | autologous stem cell transplantation | Bone disease | Osteoblasts | Autologous stem cell transplantation | Dickkopf-1 (DKK-1) | Multiple myeloma | ONCOLOGY | UNDETERMINED SIGNIFICANCE | MONOCLONAL GAMMOPATHY | INHIBITOR | BONE-RESORPTION | Multiple Myeloma - diagnosis | Humans | Middle Aged | Male | Transplantation, Autologous | Intercellular Signaling Peptides and Proteins - blood | Biomarkers, Tumor - blood | Stem Cell Transplantation | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Multiple Myeloma - surgery | Multiple Myeloma - blood
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2015, Volume 30, Issue 6, pp. 1014 - 1021
Spinal cord injury (SCI) has been associated with a marked increase in bone loss and bone remodeling, especially short‐term after injury. The absence of...
DKK‐1 | SPINAL CORD INJURY | SCLEROSTIN | WNT SIGNALING | OSTEOPOROSIS | DKK-1 | MULTIPLE-MYELOMA | INDUCED OSTEOPOROSIS | BIOCHEMICAL MARKERS | FOLLOW-UP | SERUM | CIRCULATING SCLEROSTIN | FRACTURE | MINERAL DENSITY | MEN | ENDOCRINOLOGY & METABOLISM | BED REST | Bone Resorption - etiology | Prospective Studies | Bone Resorption - blood | Follow-Up Studies | Spinal Cord Injuries - complications | Humans | Middle Aged | Male | Bone Morphogenetic Proteins - blood | Biomarkers - blood | Genetic Markers | Intercellular Signaling Peptides and Proteins - blood | Adolescent | Adult | Female | Aged | Spinal Cord Injuries - blood | Wnt Signaling Pathway | Bones | Spinal cord injuries | Density | Analysis
DKK‐1 | SPINAL CORD INJURY | SCLEROSTIN | WNT SIGNALING | OSTEOPOROSIS | DKK-1 | MULTIPLE-MYELOMA | INDUCED OSTEOPOROSIS | BIOCHEMICAL MARKERS | FOLLOW-UP | SERUM | CIRCULATING SCLEROSTIN | FRACTURE | MINERAL DENSITY | MEN | ENDOCRINOLOGY & METABOLISM | BED REST | Bone Resorption - etiology | Prospective Studies | Bone Resorption - blood | Follow-Up Studies | Spinal Cord Injuries - complications | Humans | Middle Aged | Male | Bone Morphogenetic Proteins - blood | Biomarkers - blood | Genetic Markers | Intercellular Signaling Peptides and Proteins - blood | Adolescent | Adult | Female | Aged | Spinal Cord Injuries - blood | Wnt Signaling Pathway | Bones | Spinal cord injuries | Density | Analysis
Journal Article
The Prostate, ISSN 0270-4137, 05/2011, Volume 71, Issue 6, pp. 615 - 625
BACKGROUND Osteoblastic bone metastasis is the predominant phenotype observed in prostate cancer patients and is associated with high patient mortality and...
DKK‐1 | metastasis | prostate cancer | DKK-1 | WNT SIGNALING PATHWAY | MULTIPLE-MYELOMA | CELLS | MECHANISM | SKELETAL COMPLICATIONS | MESSENGER-RNA | GASTRIC-CANCER | MOUSE MODEL | IN-VIVO | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | UP-REGULATION | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Osteogenesis - physiology | Signal Transduction | Intercellular Signaling Peptides and Proteins - genetics | Bone Neoplasms - secondary | Cell Growth Processes - physiology | Male | Tomography, X-Ray Computed | Wnt Proteins - metabolism | Bone Neoplasms - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Animals | Mice, Nude | Dogs | Histocytochemistry | Statistics, Nonparametric | Cell Line, Tumor | Mice | Wnt Proteins - antagonists & inhibitors | Prostate cancer
DKK‐1 | metastasis | prostate cancer | DKK-1 | WNT SIGNALING PATHWAY | MULTIPLE-MYELOMA | CELLS | MECHANISM | SKELETAL COMPLICATIONS | MESSENGER-RNA | GASTRIC-CANCER | MOUSE MODEL | IN-VIVO | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | UP-REGULATION | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Osteogenesis - physiology | Signal Transduction | Intercellular Signaling Peptides and Proteins - genetics | Bone Neoplasms - secondary | Cell Growth Processes - physiology | Male | Tomography, X-Ray Computed | Wnt Proteins - metabolism | Bone Neoplasms - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Animals | Mice, Nude | Dogs | Histocytochemistry | Statistics, Nonparametric | Cell Line, Tumor | Mice | Wnt Proteins - antagonists & inhibitors | Prostate cancer
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 09/2016, Volume 51, Issue 9, pp. 1133 - 1137
Background: Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide. It has been widely established that the early detection of HCC...
HCC | AFP | DKK 1 | hepatitis C | GASTROENTEROLOGY & HEPATOLOGY | CANCER | DKK1 | Multivariate Analysis | Hepatitis C, Chronic - pathology | Prospective Studies | Humans | Middle Aged | Egypt | Linear Models | Male | Liver Cirrhosis - blood | Hepatitis C, Chronic - blood | alpha-Fetoproteins - analysis | Intercellular Signaling Peptides and Proteins - blood | Biomarkers, Tumor - blood | Liver Neoplasms - blood | Sensitivity and Specificity | Liver Cirrhosis - pathology | Adult | Female | ROC Curve | Aged | Carcinoma, Hepatocellular - blood
HCC | AFP | DKK 1 | hepatitis C | GASTROENTEROLOGY & HEPATOLOGY | CANCER | DKK1 | Multivariate Analysis | Hepatitis C, Chronic - pathology | Prospective Studies | Humans | Middle Aged | Egypt | Linear Models | Male | Liver Cirrhosis - blood | Hepatitis C, Chronic - blood | alpha-Fetoproteins - analysis | Intercellular Signaling Peptides and Proteins - blood | Biomarkers, Tumor - blood | Liver Neoplasms - blood | Sensitivity and Specificity | Liver Cirrhosis - pathology | Adult | Female | ROC Curve | Aged | Carcinoma, Hepatocellular - blood
Journal Article
The Oncologist, ISSN 1083-7159, 03/2009, Volume 14, Issue 3, pp. 276 - 283
Bone disease is a hallmark of multiple myeloma (MM). Occurring in the majority of MM patients, it is associated with bone pain, fractures, and hypercalcemia...
DKK‐1 | RANKL | ICTP | MIP‐1 | Multiple myeloma | Osteoblast | Osteoclast | Bone | Biochemical markers | Osteoprotegerin | MIP-1 | DKK-1 | OSTEOBLAST DIFFERENTIATION | OSTEOLYTIC LESIONS | UROKINASE PLASMINOGEN-ACTIVATOR | ADVANCED MULTIPLE-MYELOMA | SERUM CONCENTRATIONS | ONCOLOGY | IN-VIVO | RECEPTOR ACTIVATOR | OSTEOCLAST DIFFERENTIATION | KAPPA-B LIGAND | MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA | Osteoblasts - pathology | Multiple Myeloma - pathology | Multiple Myeloma - therapy | Osteoclasts - pathology | Osteolysis - therapy | Multiple Myeloma - diagnosis | Humans | Osteolysis - diagnosis | Osteolysis - pathology
DKK‐1 | RANKL | ICTP | MIP‐1 | Multiple myeloma | Osteoblast | Osteoclast | Bone | Biochemical markers | Osteoprotegerin | MIP-1 | DKK-1 | OSTEOBLAST DIFFERENTIATION | OSTEOLYTIC LESIONS | UROKINASE PLASMINOGEN-ACTIVATOR | ADVANCED MULTIPLE-MYELOMA | SERUM CONCENTRATIONS | ONCOLOGY | IN-VIVO | RECEPTOR ACTIVATOR | OSTEOCLAST DIFFERENTIATION | KAPPA-B LIGAND | MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA | Osteoblasts - pathology | Multiple Myeloma - pathology | Multiple Myeloma - therapy | Osteoclasts - pathology | Osteolysis - therapy | Multiple Myeloma - diagnosis | Humans | Osteolysis - diagnosis | Osteolysis - pathology
Journal Article
The Prostate, ISSN 0270-4137, 09/2008, Volume 68, Issue 13, pp. 1396 - 1404
BACKGROUND Prostate cancer (PCa) frequently metastasizes to the bone and induces osteoblastic lesions. We previously demonstrated through over‐expression of...
DKK‐1 | prostate cancer | bone | Wnt | metastasis | DKK-1 | Bone | Metastasis | Prostate cancer | MULTIPLE-MYELOMA | TARGET | CELLS | ANTAGONIST | BONE METASTASES | IDENTIFICATION | DKK1 | GENE | PATHWAY | OSTEOBLASTS | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Prognosis | Soft Tissue Neoplasms - secondary | Tissue Array Analysis | Humans | Lung Neoplasms - metabolism | Kaplan-Meier Estimate | Bone Neoplasms - secondary | Male | Prostatic Neoplasms - diagnosis | beta Catenin - metabolism | Disease Progression | Bone Neoplasms - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Neoplasm Metastasis | Lung Neoplasms - secondary | Biopsy | Liver Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Retrospective Studies | Liver Neoplasms - secondary
DKK‐1 | prostate cancer | bone | Wnt | metastasis | DKK-1 | Bone | Metastasis | Prostate cancer | MULTIPLE-MYELOMA | TARGET | CELLS | ANTAGONIST | BONE METASTASES | IDENTIFICATION | DKK1 | GENE | PATHWAY | OSTEOBLASTS | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Prognosis | Soft Tissue Neoplasms - secondary | Tissue Array Analysis | Humans | Lung Neoplasms - metabolism | Kaplan-Meier Estimate | Bone Neoplasms - secondary | Male | Prostatic Neoplasms - diagnosis | beta Catenin - metabolism | Disease Progression | Bone Neoplasms - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Neoplasm Metastasis | Lung Neoplasms - secondary | Biopsy | Liver Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Retrospective Studies | Liver Neoplasms - secondary
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 05/2005, Volume 1049, Issue 1, pp. 97 - 106
: Human mesenchymal stem cells (hMSCs) from bone marrow are a source of osteoblast progenitors in vivo, and under appropriate conditions they differentiate...
Dkk‐1 | bone | cancer | osteogenesis | Wnt | mesenchymal stem cells | Dkk-1 | Bone | Osteogenesis | Cancer | Mesenchymal stem cells | MULTIPLE-MYELOMA | MULTIDISCIPLINARY SCIENCES | SELF-RENEWAL | ADULT PROGENITOR CELLS | ENGRAFTMENT | GROWTH-FACTORS | GENE FAMILY | OSTEOGENESIS IMPERFECTA | DIFFERENTIATION | STROMAL CELLS | EXPRESSION | Neoplasms - metabolism | Osteogenesis - physiology | Bone Marrow Cells - cytology | Humans | Bone Marrow Cells - physiology | Wnt Proteins - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Mesenchymal Stromal Cells - cytology | Animals | Signal Transduction - physiology | Neoplasms - physiopathology | Cell Differentiation - physiology | Mesenchymal Stromal Cells - physiology | Biomedical materials | Inhibitors | Peptides | Bone marrow | Biocompatibility | Bones | Kinases | Repair
Dkk‐1 | bone | cancer | osteogenesis | Wnt | mesenchymal stem cells | Dkk-1 | Bone | Osteogenesis | Cancer | Mesenchymal stem cells | MULTIPLE-MYELOMA | MULTIDISCIPLINARY SCIENCES | SELF-RENEWAL | ADULT PROGENITOR CELLS | ENGRAFTMENT | GROWTH-FACTORS | GENE FAMILY | OSTEOGENESIS IMPERFECTA | DIFFERENTIATION | STROMAL CELLS | EXPRESSION | Neoplasms - metabolism | Osteogenesis - physiology | Bone Marrow Cells - cytology | Humans | Bone Marrow Cells - physiology | Wnt Proteins - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Mesenchymal Stromal Cells - cytology | Animals | Signal Transduction - physiology | Neoplasms - physiopathology | Cell Differentiation - physiology | Mesenchymal Stromal Cells - physiology | Biomedical materials | Inhibitors | Peptides | Bone marrow | Biocompatibility | Bones | Kinases | Repair
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 08/2014, Volume 3, Issue 4, p. n/a
Background Dickkopf‐1 (DKK‐1) is a major regulator of the Wnt signaling pathway, involved in inflammation, atherogenesis, and the regulation of glucose...
DKK‐1 | platelet‐derived factor | diabetes mellitus | inflammation | endothelial dysfunction | platelet activation | Endothelial dysfunction | DKK-1 | Inflammation | Platelet activation | Platelet-derived factor | Diabetes mellitus | WNT SIGNALING PATHWAY | CARDIAC & CARDIOVASCULAR SYSTEMS | INVOLVEMENT | PREVENTION | CD40 LIGAND | GLUCOSE | SERUM-LEVELS | DISEASE | platelet-derived factor | CALCIFICATION | TYPE-2 | Hypoglycemic Agents - therapeutic use | Cross-Sectional Studies | CD40 Ligand - blood | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Biomarkers - blood | Thromboxane B2 - analogs & derivatives | Arginine - analogs & derivatives | Case-Control Studies | Intercellular Signaling Peptides and Proteins - blood | Diabetes Mellitus, Type 2 - blood | Platelet Activation | Thromboxane B2 - urine | Arginine - blood | Female | Aged | Aspirin - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Platelet Aggregation Inhibitors - therapeutic use | Wnt Signaling Pathway
DKK‐1 | platelet‐derived factor | diabetes mellitus | inflammation | endothelial dysfunction | platelet activation | Endothelial dysfunction | DKK-1 | Inflammation | Platelet activation | Platelet-derived factor | Diabetes mellitus | WNT SIGNALING PATHWAY | CARDIAC & CARDIOVASCULAR SYSTEMS | INVOLVEMENT | PREVENTION | CD40 LIGAND | GLUCOSE | SERUM-LEVELS | DISEASE | platelet-derived factor | CALCIFICATION | TYPE-2 | Hypoglycemic Agents - therapeutic use | Cross-Sectional Studies | CD40 Ligand - blood | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Biomarkers - blood | Thromboxane B2 - analogs & derivatives | Arginine - analogs & derivatives | Case-Control Studies | Intercellular Signaling Peptides and Proteins - blood | Diabetes Mellitus, Type 2 - blood | Platelet Activation | Thromboxane B2 - urine | Arginine - blood | Female | Aged | Aspirin - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Platelet Aggregation Inhibitors - therapeutic use | Wnt Signaling Pathway
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2010, Volume 126, Issue 7, pp. 1611 - 1620
The protein products of the Dickkopf (DKK) genes are antagonists of Wnt glycoproteins, which participate in tumor development and progression by binding to...
DKK‐1 | ductal adenocarcinoma | pancreatic cancer | wnt signal | Ductal adenocarcinoma | DKK-1 | Wnt signal | Pancreatic cancer | ANTAGONIST | HEPATOBLASTOMAS | GENE-EXPRESSION PROFILES | BETA-CATENIN | TUMORS | FAMILY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | EPIGENETIC INACTIVATION | CANCER BONE METASTASES | Cell Proliferation | Pancreatic Neoplasms - metabolism | Humans | Carcinoma, Pancreatic Ductal - metabolism | Immunoblotting | Male | RNA, Messenger - metabolism | Immunoenzyme Techniques | Carcinoma, Pancreatic Ductal - genetics | Intercellular Signaling Peptides and Proteins - metabolism | Tumor Cells, Cultured | Neoplasm Invasiveness | Pancreatic Neoplasms - pathology | RNA, Messenger - genetics | RNA, Small Interfering - pharmacology | Intercellular Signaling Peptides and Proteins - genetics | Pancreatic Neoplasms - genetics | Reverse Transcriptase Polymerase Chain Reaction | Carcinoma, Pancreatic Ductal - pathology | Blotting, Western | Animals | Mice, Nude | Mice | Mice, Inbred BALB C | Apoptosis | Cell Movement
DKK‐1 | ductal adenocarcinoma | pancreatic cancer | wnt signal | Ductal adenocarcinoma | DKK-1 | Wnt signal | Pancreatic cancer | ANTAGONIST | HEPATOBLASTOMAS | GENE-EXPRESSION PROFILES | BETA-CATENIN | TUMORS | FAMILY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | EPIGENETIC INACTIVATION | CANCER BONE METASTASES | Cell Proliferation | Pancreatic Neoplasms - metabolism | Humans | Carcinoma, Pancreatic Ductal - metabolism | Immunoblotting | Male | RNA, Messenger - metabolism | Immunoenzyme Techniques | Carcinoma, Pancreatic Ductal - genetics | Intercellular Signaling Peptides and Proteins - metabolism | Tumor Cells, Cultured | Neoplasm Invasiveness | Pancreatic Neoplasms - pathology | RNA, Messenger - genetics | RNA, Small Interfering - pharmacology | Intercellular Signaling Peptides and Proteins - genetics | Pancreatic Neoplasms - genetics | Reverse Transcriptase Polymerase Chain Reaction | Carcinoma, Pancreatic Ductal - pathology | Blotting, Western | Animals | Mice, Nude | Mice | Mice, Inbred BALB C | Apoptosis | Cell Movement
Journal Article
IUBMB Life, ISSN 1521-6543, 07/2016, Volume 68, Issue 7, pp. 597 - 601
In this study, we investigated the expression levels of Dickkopf‐1 (DKK‐1) and programmed cell death 5 (PDCD5) by using quantitative real‐time PCR and...
chondrosarcoma | immunohistochemistry | DKK‐1 and PDCD5 | PCR | patients | Immunohistochemistry | Chondrosarcoma | DKK-1 and PDCD5 | Patients | APOPTOSIS | ANTAGONIST | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-DEATH 5 | DICKKOPF-1 | TUMORS | CELL BIOLOGY | BREAST-CANCER | GENE | PROSTATE-CANCER | OSTEOSARCOMA | REDUCED EXPRESSION | Apoptosis Regulatory Proteins - biosynthesis | Prognosis | Neoplasm Proteins - biosynthesis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Kaplan-Meier Estimate | Intercellular Signaling Peptides and Proteins - biosynthesis | Male | RNA, Messenger - biosynthesis | Apoptosis Regulatory Proteins - genetics | Cell Line, Tumor | Chondrosarcoma - genetics | Chondrosarcoma - pathology | Adult | Female | Aged | Biomarkers, Tumor - genetics | Neoplasm Proteins - genetics | Biomarkers, Tumor - biosynthesis | Investigations
chondrosarcoma | immunohistochemistry | DKK‐1 and PDCD5 | PCR | patients | Immunohistochemistry | Chondrosarcoma | DKK-1 and PDCD5 | Patients | APOPTOSIS | ANTAGONIST | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-DEATH 5 | DICKKOPF-1 | TUMORS | CELL BIOLOGY | BREAST-CANCER | GENE | PROSTATE-CANCER | OSTEOSARCOMA | REDUCED EXPRESSION | Apoptosis Regulatory Proteins - biosynthesis | Prognosis | Neoplasm Proteins - biosynthesis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Kaplan-Meier Estimate | Intercellular Signaling Peptides and Proteins - biosynthesis | Male | RNA, Messenger - biosynthesis | Apoptosis Regulatory Proteins - genetics | Cell Line, Tumor | Chondrosarcoma - genetics | Chondrosarcoma - pathology | Adult | Female | Aged | Biomarkers, Tumor - genetics | Neoplasm Proteins - genetics | Biomarkers, Tumor - biosynthesis | Investigations
Journal Article